MyChesCo on MSN3d
Savara Reports 2024 Financial Results and Provides Updates on MOLBREEVI Progress
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has announced its financial results for the fourth quarter and fiscal year 2024, ...
MyChesCo on MSN3d
Savara Secures $200 Million Loan Agreement with Hercules Capital
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has announced a strategic loan and security agreement with Hercules Capital, Inc. ...
Savara Reports Fourth Quarter and Year End 2024 Financial Results and Provides Business Update
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, ...
Savara Inc (NASDAQ:SVRA) Shares Sold by Swiss National Bank
Swiss National Bank lessened its position in shares of Savara Inc (NASDAQ:SVRA – Free Report) by 6.7% during the fourth ...
Savara Enters Into Non-Dilutive Debt Financing for up to $200M With Hercules Capital
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, ...
Nasdaq3d
SAVARA Earnings Preview: Recent $SVRA Insider Trading, Hedge Fund Activity, and More
SAVARA ($SVRA) is expected to release its quarterly earnings data on Wednesday, April 2nd after market close, per Finnhub. Analysts are expecting revenue of $0 and ...
Analysts Conflicted on These Healthcare Names: Savara (SVRA) and Zentalis Pharmaceuticals (ZNTL)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Savara (SVRA – Research Report) and Zentalis Pharmaceuticals ...
Evercore ISI Keeps Their Hold Rating on Savara (SVRA)
Evercore ISI analyst Liisa Bayko maintained a Hold rating on Savara (SVRA – Research Report) yesterday and set a price target of $3.00. The ...
Charles Schwab Investment Management Inc. Buys 52,204 Shares of Savara Inc (NASDAQ:SVRA)
Charles Schwab Investment Management Inc. grew its position in shares of Savara Inc (NASDAQ:SVRA – Free Report) by 5.7% ...
Morningstar8d
Savara Enters Into Non-Dilutive Debt Financing for up to $200M With Hercules Capital
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that it has entered into a loan and security agreement ...
The Bakersfield Californian8d
Savara Reports Fourth Quarter and Year End 2024 Financial Results and Provides Business Update
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the fourth quarter and full year ending ...